Six ERP Obstacles Holding Back Emerging Biopharma

Emerging biopharma companies face a unique squeeze: they must build enterprise-grade operations while conserving capital for the pipeline. Systems chosen in the lab often buckle under clinical supply, partner networks and investor scrutiny.

We surveyed finance, supply chain and IT leaders at growing biopharma companies to learn what slows their ERP programs down — and what the fastest-moving companies do differently. Download the report to benchmark your own readiness.

Discover insights on:

• The six obstacles leaders cite most often, from data quality to validation
• How timing an ERP program around clinical milestones reduces risk
• The steps top performers take to scale operations without adding complexity